Stockreport

Addex Amends its at the Market Offering Agreement With H.C. Wainwright & Co.

Addex Therapeutics Ltd - American Depositary Shares  (ADXN) 
PDF Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, December 11, 2025 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical compan [Read more]